Financial News
Exagen Inc (NQ: XGN )
1.920
-0.040
(-2.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Exagen Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's After-Market Session
October 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
October 05, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
September 28, 2023
From Exagen Inc.
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Exagen's Earnings Outlook
August 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Exagen: Q1 Earnings Insights
May 15, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Exagen Q1 Earnings
May 15, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_176.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 26, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 19, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 12, 2023
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. Reports Strong Second Quarter 2023 Results
August 07, 2023
From Exagen Inc.
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Exagen Earnings Perspective: Return On Capital Employed
March 21, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Exagen Earnings Preview
March 17, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. Appoints Paul Kim to Board of Directors
July 24, 2023
From Exagen Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1974.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
From Exagen Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/03/21/image49.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. to Participate in Upcoming March Conferences
February 27, 2023
From Exagen Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/02/15/screenshot_2023-02-15_at_8.33.06_pm.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
January 23, 2023
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 28, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.